Balance Sheet
Accounts PayablesAccumulated ExpensesCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent TaxesGoodwill & IntangiblesInventoryLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zhengye Biotechnology Holding (ZYBT) Current Assets: 2023-2024

Historic Current Assets for Zhengye Biotechnology Holding (ZYBT) over the last 2 years, with Dec 2024 value amounting to $24.3 million.

  • Zhengye Biotechnology Holding's Current Assets was N/A to $27.9 million in Q2 2025 from the same period last year, while for Jun 2025 it was $27.9 million, marking a year-over-year change of. This contributed to the annual value of $24.3 million for FY2024, which is 9.15% down from last year.
  • Per Zhengye Biotechnology Holding's latest filing, its Current Assets stood at $24.3 million for FY2024, which was down 9.15% from $26.8 million recorded in FY2023.
  • Over the past 5 years, Zhengye Biotechnology Holding's Current Assets peaked at $26.8 million during FY2023, and registered a low of $24.3 million during FY2024.
  • In the last 2 years, Zhengye Biotechnology Holding's Current Assets had a median value of $25.6 million in 2023 and averaged $25.6 million.
  • Data for Zhengye Biotechnology Holding's Current Assets shows a maximum YoY decreased of 9.15% (in 2024) over the last 5 years.
  • Zhengye Biotechnology Holding's Current Assets (Yearly) stood at $26.8 million in 2023, then fell by 9.15% to $24.3 million in 2024.